Document Detail

Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity.
MedLine Citation:
PMID:  23221964     Owner:  NLM     Status:  Publisher    
PURPOSE: To evaluate ocular outcome in premature infants treated with intravitreal ranibizumab injections for retinopathy of prematurity (ROP) over a period of 3 years. METHODS: An interventional case series. Premature infants with high-risk prethreshold or threshold ROP with plus disease received an off label monotherapy with intravitreal injections of ranibizumab. The primary outcome was treatment success defined as regression of neovascularisation (NV) and absence of recurrence. The secondary outcomes were ocular and systemic adverse events and visual acuity. RESULTS: Six eyes were included in the study and treated with intravitreal injections of ranibizumab. All showed complete resolution of NV after a single injection. The anti-angiogenic intravitreal injections allowed for continued normal vessel growth into the peripheral retina, without any signs of disease recurrence or progression during the follow up period. No ocular or systemic adverse effects were observed. CONCLUSIONS: Three years of follow up in a small series suggest that intravitreal ranibizumab injections for ROP result in apparently preserved ocular outcome. Further large scale studies are needed to address the long-term safety and efficacy.
María Ana Martínez Castellanos; Shulamit Schwartz; Gerardo García-Aguirre; Hugo Quiroz-Mercado
Related Documents :
1960634 - Hematocrit in relation to apgar scores in sga infants.
23536044 - Use of baclofen for withdrawal in a preterm infant.
21796154 - Effects of a 17q21 chromosome gene variant, tobacco smoke and furred pets on infant whe...
11344794 - A four year survey of neonatal narcotic withdrawal: evaluation and treatment.
10215544 - Thumb/hallux duplication and preaxial polydactyly type i.
19620674 - Does a calf's motivation to ingest colostrum depend on time since birth, calf vigor, or...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-8
Journal Detail:
Title:  The British journal of ophthalmology     Volume:  -     ISSN:  1468-2079     ISO Abbreviation:  Br J Ophthalmol     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0421041     Medline TA:  Br J Ophthalmol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Asociación para Evitar la Ceguera en México, Hospital "Luis Sanchez Bulnes" I.A.P., Mexico City, Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The cost of transport of human running is not affected, as in walking, by wide acceleration/decelera...
Next Document:  Clinical and genetic features in Italian Bietti crystalline dystrophy patients.